299 related articles for article (PubMed ID: 25340260)
21. Comparative Analysis of Human Mesenchymal Stem Cells Derived From Bone Marrow, Placenta, and Adipose Tissue as Sources of Cell Therapy.
Jeon YJ; Kim J; Cho JH; Chung HM; Chae JI
J Cell Biochem; 2016 May; 117(5):1112-25. PubMed ID: 26448537
[TBL] [Abstract][Full Text] [Related]
22. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?
El Omar R; Beroud J; Stoltz JF; Menu P; Velot E; Decot V
Tissue Eng Part B Rev; 2014 Oct; 20(5):523-44. PubMed ID: 24552279
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro.
Bochev I; Elmadjian G; Kyurkchiev D; Tzvetanov L; Altankova I; Tivchev P; Kyurkchiev S
Cell Biol Int; 2008 Apr; 32(4):384-93. PubMed ID: 18262807
[TBL] [Abstract][Full Text] [Related]
24. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
Bhonde RR; Sheshadri P; Sharma S; Kumar A
Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096
[TBL] [Abstract][Full Text] [Related]
25. Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells.
Kang JW; Kang KS; Koo HC; Park JR; Choi EW; Park YH
Stem Cells Dev; 2008 Aug; 17(4):681-93. PubMed ID: 18717642
[TBL] [Abstract][Full Text] [Related]
26. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.
Chao YH; Wu HP; Wu KH; Tsai YG; Peng CT; Lin KC; Chao WR; Lee MS; Fu YC
PLoS One; 2014; 9(10):e110338. PubMed ID: 25337817
[TBL] [Abstract][Full Text] [Related]
27. Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research.
Frausin S; Viventi S; Verga Falzacappa L; Quattromani MJ; Leanza G; Tommasini A; Valencic E
Acta Histochem; 2015; 117(4-5):329-38. PubMed ID: 25747736
[TBL] [Abstract][Full Text] [Related]
28. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells.
Lee JM; Jung J; Lee HJ; Jeong SJ; Cho KJ; Hwang SG; Kim GJ
Int Immunopharmacol; 2012 Jun; 13(2):219-24. PubMed ID: 22487126
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
Markov A; Thangavelu L; Aravindhan S; Zekiy AO; Jarahian M; Chartrand MS; Pathak Y; Marofi F; Shamlou S; Hassanzadeh A
Stem Cell Res Ther; 2021 Mar; 12(1):192. PubMed ID: 33736695
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells: Mechanisms of immunomodulation and homing.
Yagi H; Soto-Gutierrez A; Parekkadan B; Kitagawa Y; Tompkins RG; Kobayashi N; Yarmush ML
Cell Transplant; 2010; 19(6):667-79. PubMed ID: 20525442
[TBL] [Abstract][Full Text] [Related]
31. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
[TBL] [Abstract][Full Text] [Related]
32. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
33. Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells.
Liu S; Yuan M; Hou K; Zhang L; Zheng X; Zhao B; Sui X; Xu W; Lu S; Guo Q
Cell Immunol; 2012; 278(1-2):35-44. PubMed ID: 23121974
[TBL] [Abstract][Full Text] [Related]
34. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cells and infectious diseases: Smarter than drugs.
Mezey É; Nemeth K
Immunol Lett; 2015 Dec; 168(2):208-14. PubMed ID: 26051681
[TBL] [Abstract][Full Text] [Related]
36. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.
Soleymaninejadian E; Pramanik K; Samadian E
Am J Reprod Immunol; 2012 Jan; 67(1):1-8. PubMed ID: 21951555
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.
Tomic S; Djokic J; Vasilijic S; Vucevic D; Todorovic V; Supic G; Colic M
Stem Cells Dev; 2011 Apr; 20(4):695-708. PubMed ID: 20731536
[TBL] [Abstract][Full Text] [Related]
38. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
Najar M; Raicevic G; Boufker HI; Fayyad-Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2010 Nov; 16(11):3537-46. PubMed ID: 20597819
[TBL] [Abstract][Full Text] [Related]
39. The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis.
Ho MS; Mei SH; Stewart DJ
J Cell Physiol; 2015 Nov; 230(11):2606-17. PubMed ID: 25913273
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cells as immunomodulator therapies for immune-mediated systemic dermatoses.
Reddy BY; Xu DS; Hantash BM
Stem Cells Dev; 2012 Feb; 21(3):352-62. PubMed ID: 21864110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
